TEM MicroED Platform for High-Throughput Microcrystal Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for obtaining atomic-resolution crystal structures of small molecules and drug-protein complexes face challenges due to the difficulty in growing large, high-quality crystals, leading to time-consuming and inefficient screening processes, especially when samples fail to crystallize readily.

Innovation Solution

Combining microarraying technology with microED to perform high-throughput analysis of drug-protein interactions and crystalline sponge soaking, enabling the deposition of hundreds of microcrystals or crystalline sponges onto a single TEM grid for rapid screening using microED.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If single crystal X-ray diffraction (SCXRD) is used to obtain atomic-resolution crystal structures, then measurement precision is improved, but productivity deteriorates due to time-consuming crystal growth screening

Engineering Contradiction:
Improveatomic-resolution crystal structure determinationVSAvoidscreening throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The invention segments the crystal screening process by microarraying hundreds of microcrystals onto a single TEM grid, allowing parallel analysis of multiple samples in one experiment. This segmentation transforms the sequential screening bottleneck into a parallelized high-throughput workflow while maintaining microED's atomic-resolution capability.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If large single crystals are grown for SCXRD analysis, then measurement precision is improved, but loss of time increases due to extensive screening requirements

Engineering Contradiction:
Improvecrystal structure qualityVSAvoidcrystal growth and screening time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention uses disposable microcrystals (approximately -1 μm3 or less) that do not require extensive growth time. These microcrystals can be obtained from failed SCXRD trials or amorphous powders, eliminating the time-consuming crystal growth step while still providing sufficient quality for microED analysis.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Adaptability or versatility

If crystal soaking is performed with large single crystals, then drug-protein interaction study is enabled, but diffusion of small molecule analyte deteriorates

Engineering Contradiction:
Improvedrug-protein interaction analysis capabilityVSAvoidsmall molecule diffusion into crystal
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The invention transitions from studying drug-protein interactions in large 3D single crystals to analyzing microcrystals on a 2D TEM grid surface. This dimensional change dramatically increases the surface-area-to-volume ratio, enabling rapid diffusion of small molecule analytes into the crystal lattice during soaking while maintaining the ability to study drug-protein interactions.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces the time required for sample screening and increases the throughput of data collection by allowing simultaneous analysis of multiple samples, overcoming the limitations of traditional crystallographic methods.

Implementation Method 1

microED for diffraction

Methodology Applied
Scientific EffectElectron diffraction: Diffraction

Data Source

PatentUS12429441B2High throughput drug discovery platform with TEM
Publication Date: 2025.09.30 RGT UNIV OF CALIFORNIA
  • US12429441B2 patent drawing
  • US12429441B2 patent drawing
  • US12429441B2 patent drawing

AI summary

The present disclosure relates to methods of obtaining electron diffraction data of microcrystalline samples.